β-keratose [107], ECMs (collagen, elastin, and hyaluronan) and growth factors (B-FGF, H-EGF, and KGF) [70], laccase [108], soybean protein isolate [13], involucrin antibody SY5 [109], papain [110] have been used for the development of BC-based wound dressings. The gene discussed is EGF; the disease is breast cancer.